Neuraxis NRXS Ratios (2022-2026)

NYSE NRXS
$5.72 -0.01 (-0.17%)
As of: Sep 10, 2026 · 11:21 AM EDT
Reported Financials

Neuraxis Quarterly Ratios

Periods 17 quarters
Latest Jun 2026

Neuraxis ratios data for the quarter ended Jun 2026. These financial ratios cover 17 quarters of results from Jun 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin 88.42%89.07%87.73%88.09%89.50%85.91%86.39%88.39%87.99%85.44%86.20%84.43%83.60%83.30%85.37%
EBT Margin -103.14%-210.71%-186.53%-131.41%-203.13%-654.06%-309.67%-287.44%-455.23%-257.41%-192.68%-256.50%-193.64%-262.47%-180.30%
EBIT Margin -98.10%-194.43%-160.86%-111.32%-172.99%-633.00%-305.42%-283.33%-360.89%-247.71%-192.68%-256.25%-192.14%-258.82%-177.34%
EBITDA Margin -98.10%-194.43%-160.86%-111.32%-172.99%-633.00%-305.42%-283.33%-360.89%-247.71%-192.68%-256.25%-192.14%-258.82%-177.34%
Operating Margin -98.10%-194.43%-160.86%-111.32%-172.99%-633.00%-305.42%-283.33%-360.89%-247.71%-192.68%-256.25%-192.14%-258.82%-177.34%
Net Margin -250.11%-367.24%-33.67%-131.41%-375.58%-1,027.18%-999.76%-327.95%-477.14%-270.02%-212.09%-278.26%-212.27%-286.11%-196.62%
FCF Margin -147.35%-33.33%-78.31%-97.47%-590.41%-497.80%-208.29%-265.55%-209.59%-230.98%-181.06%-164.95%-175.93%-200.39%
Efficiency
Inventory AverageInventory Avg. 0.04M0.03M0.02M0.03M0.03M0.03M0.04M0.08M0.12M0.18M
Assets AverageAssets Avg. 1.39M0.87M0.73M1.79M1.89M2.95M3.89M5.06M6.43M6.09M
Invested CapitalInvested Cap. -3.64M-5.10M-7.67M-0.67M1.39M-1.88M-0.49M-1.65M2.22M0.34M4.37M2.48M100.15M
Asset Utilization RatioAsset Util. 1.832.823.161.271.300.910.750.640.520.59
Leverage & Solvency
Interest Coverage RatioInterest Cover -19.44-11.94-6.27-5.54-5.74-29.45-71.99-68.98-3.83-25.53-0.00M-127.87-70.80-59.95
Debt Ratio 1.311.500.315.491.371.810.130.030.030.020.030.02
Times Interest Earned -19.44-11.94-6.27-5.54-5.74-29.45-71.99-68.98-3.83-25.53-0.00M-127.87-70.80-59.95
Valuation
Price to EarningsP/E -2.81-1.63-9.70-6.52-11.56-10.18-6.22-12.57-13.12-25.41
Price to SalesP/S 28.8516.3431.8231.1031.2021.5817.3226.6837.5349.96
Price to BookP/B -12.98-6.19-6.46-3.62-11.607.9460.025.6113.330.480.850.91
Enterprise Value 13.02M8.61M20.49M17.25M20.54M12.73M13.51M17.87M26.07M43.40M77.65M82.82M
EV to EBIT -4.31-5.30-11.19-7.82-12.44-8.68-5.89-10.40-12.42-25.28
EV to EBITDA -4.31-5.30-11.19-7.82-12.44-8.68-5.89-10.40-12.42-25.28
Market Capitalization 13.78M8.68M20.58M19.02M20.80M16.43M15.51M23.86M30.45M48.36M84.73M91.14M
Price to FCFP/FCF -4.89-3.28-15.28-11.71-14.89-9.34-9.57-16.18-21.33-24.93
EV to FCF -4.62-3.25-15.22-10.63-14.70-7.24-8.33-12.12-18.26-22.37
EV to CFO -4.62-3.27-15.38-10.68-14.75-7.24-8.42-12.18-18.26-22.44
Return Ratios
Return on Sales [ROS]ROS -98.10%-194.43%-160.86%-111.32%-172.99%-633.00%-305.42%-283.33%-360.89%-247.71%-192.68%-256.25%-192.14%-258.82%-177.34%
Return on Capital Employed [ROCE]ROCE 692.35%657.42%245.95%149.62%942.67%-1,384.04%-425.10%-262.97%-230.73%-237.41%
Return on Assets [ROA]ROA -478.21%-818.01%-1,091.17%-525.89%-423.88%-265.21%-212.23%-142.54%-118.54%-129.78%